Datasets:
anaili
/
title_BREAST_embdeddings

Dataset card Data Studio Files
xet
Community
1
NCT Number
stringlengths
11
11
Study Title
stringlengths
18
300
Study URL
stringlengths
44
44
Study Status
stringclasses
13 values
Conditions
stringlengths
3
11.1k
⌀
Interventions
stringlengths
5
1.2k
⌀
Sponsor
stringlengths
3
121
Collaborators
stringlengths
2
3.21k
⌀
Study Type
stringclasses
3 values
NCT01252277
Breast Cancer Risk Biomarkers in Premenopausal Women
https://clinicaltrials.gov/study/NCT01252277
COMPLETED
Breast Cancer
DRUG: Lovaza™
Carol Fabian, MD
null
INTERVENTIONAL
NCT00390377
Use of Hair to Diagnose Breast Cancer
https://clinicaltrials.gov/study/NCT00390377
UNKNOWN
Breast Cancer
PROCEDURE: Cutting scalp hair
Fermiscan Ltd
null
INTERVENTIONAL
NCT01088477
Imaging of ER Density to Guide and Improve Tailored Therapy for Acquired Anti-hormonal Resistant Breast Cancer
https://clinicaltrials.gov/study/NCT01088477
COMPLETED
Breast Cancer
OTHER: Diagnostic intervention: Positron Emission Tomography with 16-alpha-[18-fluoro]-17betaestradiol
University Medical Center Groningen
Dutch Cancer Society
OBSERVATIONAL
NCT00793377
Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer
https://clinicaltrials.gov/study/NCT00793377
COMPLETED
Primary Breast Cancer
DRUG: Adriamycin (Doxorubicin), Docetaxel, Tamoxifen|DRUG: Adriamycin (Doxorubicin), Docetaxel, Tamoxifen, Cyclophosphamid
German Breast Group
German Adjuvant Breast Cancer Group
INTERVENTIONAL
NCT04461977
Acupuncture for Peripheral Neuropathy Induced by Paclitaxel in Early Stage Breast Cancer
https://clinicaltrials.gov/study/NCT04461977
UNKNOWN
Peripheral Neuropathy Due to Chemotherapy
OTHER: True acupuncture|OTHER: Sham acupuncture
Instituto Brasileiro de Controle do Cancer
null
INTERVENTIONAL
NCT06188494
UNFOLD Study Egypt
https://clinicaltrials.gov/study/NCT06188494
NOT_YET_RECRUITING
Breast Cancer
null
AstraZeneca
null
OBSERVATIONAL
NCT05422794
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
https://clinicaltrials.gov/study/NCT05422794
RECRUITING
Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Locally Advanced Triple-Negative Breast Carcinoma|Metastatic Triple-Negative Breast Carcinoma|Unresectable Triple-Negative Breast Carcinoma
DRUG: BET Bromodomain Inhibitor ZEN-3694|PROCEDURE: Biopsy|PROCEDURE: Biospecimen Collection|PROCEDURE: Computed Tomography|PROCEDURE: Magnetic Resonance Imaging|DRUG: Nab-paclitaxel|BIOLOGICAL: Pembrolizumab
National Cancer Institute (NCI)
null
INTERVENTIONAL
NCT05122494
A Phase Ⅲ Study of the Efficacy and Safety of Hemay022+Aromatase Inhibitor(AI) in Participants With ER+/HER2+ Advanced or Metastatic Breast Cancer
https://clinicaltrials.gov/study/NCT05122494
RECRUITING
Breast Cancer
DRUG: Hemay022+AI|DRUG: Lapatinib+Capecitabine
Tianjin Hemay Oncology Pharmaceutical Co., Ltd
null
INTERVENTIONAL
NCT05000294
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
https://clinicaltrials.gov/study/NCT05000294
SUSPENDED
Bile Duct Cancer|Gall Bladder Cancer|Breast Cancer|Neuroendocrine Tumors|Ovarian Cancer|Pancreatic Adenocarcinoma|Soft Tissue Sarcoma|Vulvar Cancer|Prostate Cancer
DRUG: Atezolizumab|DRUG: Tivozanib
University of Florida
Genentech, Inc.|Aveo Oncology Pharmaceuticals
INTERVENTIONAL
NCT00790894
Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT)
https://clinicaltrials.gov/study/NCT00790894
TERMINATED
Metastatic Breast Cancer
DRUG: ixabepilone|DRUG: ixabepilone
Hellenic Cooperative Oncology Group
null
INTERVENTIONAL
NCT05134194
A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast Cancer
https://clinicaltrials.gov/study/NCT05134194
UNKNOWN
Triple Negative Breast Cancer
DRUG: Camrelizumab、Capecitabine/eribulin/gemcitabine/vinorelbine|DRUG: Capecitabine/eribulin/gemcitabine/vinorelbine
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
null
INTERVENTIONAL
NCT01222377
Endoscopic Breast Surgery in Treating Patients With Breast Cancer
https://clinicaltrials.gov/study/NCT01222377
TERMINATED
Male Breast Cancer|Recurrent Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer
PROCEDURE: endoscopic surgery|PROCEDURE: quality-of-life assessment
University of Southern California
National Cancer Institute (NCI)
INTERVENTIONAL
NCT02569294
Feasibility and Impact of Group Interventions on Breast Cancer Patients Well-being
https://clinicaltrials.gov/study/NCT02569294
COMPLETED
Breast Cancer
BEHAVIORAL: Yoga intervention|BEHAVIORAL: Hypnosis intervention|BEHAVIORAL: CBT intervention
University of Liege
null
INTERVENTIONAL
NCT04147494
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
https://clinicaltrials.gov/study/NCT04147494
RECRUITING
Breast Carcinoma|Colon Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Head and Neck Carcinoma|Kidney Carcinoma|Lung Carcinoma|Ovarian Carcinoma|Pancreatic Carcinoma|Solid Neoplasm|Uterine Corpus Cancer
PROCEDURE: Computed Tomography|RADIATION: Gallium Ga 68 FAPi-46|RADIATION: Gallium Ga 68-labeled PSMA-11|PROCEDURE: Positron Emission Tomography|RADIATION: 18F-FDG
Jonsson Comprehensive Cancer Center
Society of Nuclear Medecine and Molecular Imaging
INTERVENTIONAL
NCT03328494
Study of Paclitaxel in Combination With BOS172722 in Patients With Advanced Nonhaematologic Malignancies
https://clinicaltrials.gov/study/NCT03328494
COMPLETED
Advanced Nonhaematologic Malignancies
DRUG: BOS172722|DRUG: Paclitaxel
Boston Pharmaceuticals
null
INTERVENTIONAL
NCT02991677
Exercise Effect on Chemotherapy-Induced Neuropathic Pain
https://clinicaltrials.gov/study/NCT02991677
UNKNOWN
Cancer, Breast|Cancer, Colorectal|Cancer, Lung|Cancer, Ovarian
BEHAVIORAL: aerobic exercise intervention|OTHER: control group|BEHAVIORAL: resistive training
Baltimore VA Medical Center
null
INTERVENTIONAL
NCT01275677
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
https://clinicaltrials.gov/study/NCT01275677
ACTIVE_NOT_RECRUITING
HER2/Neu Positive|Progesterone Receptor Positive|Recurrent Breast Carcinoma|Stage IA Breast Cancer AJCC v7|Stage IB Breast Cancer AJCC v7|Stage IIA Breast Cancer AJCC v6 and v7|Stage IIB Breast Cancer AJCC v6 and v7|Stage IIIA Breast Cancer AJCC v7|Stage IIIC Breast Cancer AJCC v7
DRUG: Cyclophosphamide|DRUG: Docetaxel|DRUG: Doxorubicin|DRUG: Doxorubicin Hydrochloride|OTHER: Laboratory Biomarker Analysis|DRUG: Paclitaxel|OTHER: Quality-of-Life Assessment|BIOLOGICAL: Trastuzumab
National Cancer Institute (NCI)
NRG Oncology
INTERVENTIONAL
NCT05968677
Effect of an Amino Acids and Flavonoids Containing FSMP on Chemotherapy Toxicity, Nutritional Status and Quality of Life in Breast Cancer Patients
https://clinicaltrials.gov/study/NCT05968677
RECRUITING
Breast Cancer
DIETARY_SUPPLEMENT: FSMP|OTHER: Nutritional counseling
Flavolife Srl
null
INTERVENTIONAL
NCT05291494
A Study on the Effectiveness of WeChat-based Online Education to Reduce Perioperative Anxiety in Breast Cancer Patients
https://clinicaltrials.gov/study/NCT05291494
COMPLETED
Breast Cancer Female
BEHAVIORAL: follow the WeChat public platform to watch the education videos|BEHAVIORAL: regular preoperative visits and education by ward nurses.
West China Hospital
null
INTERVENTIONAL
NCT04532177
Stereotactic Body Radiation Therapy (SBRT) for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery
https://clinicaltrials.gov/study/NCT04532177
ACTIVE_NOT_RECRUITING
Breast Cancer
RADIATION: Stereotactic Body Radiation Therapy (SBRT)
Stony Brook University
null
INTERVENTIONAL
NCT03106077
Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer
https://clinicaltrials.gov/study/NCT03106077
COMPLETED
Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage IIA Breast Cancer AJCC v8|Anatomic Stage IIB Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Estrogen Receptor Negative|Folate Receptor Alpha Positive|HER2/Neu Negative|Progesterone Receptor Negative|Prognostic Stage II Breast Cancer AJCC v8|Prognostic Stage IIA Breast Cancer AJCC v8|Prognostic Stage IIB Breast Cancer AJCC v8|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8|Triple-Negative Breast Carcinoma
BIOLOGICAL: Mirvetuximab Soravtansine
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
INTERVENTIONAL
NCT03888677
Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer
https://clinicaltrials.gov/study/NCT03888677
COMPLETED
Breast Cancer
DRUG: 5-FU, epirubicin and cyclophosphamide
Henrik Lindman
Scandinavian Breast Group|Danish Breast Cancer Cooperative Group|Swedish Cancer Society|Swedish Cancer Foundation|Pharmacia Pharmaceutical Company|Swedish Breast Cancer Group
INTERVENTIONAL
NCT05288777
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
https://clinicaltrials.gov/study/NCT05288777
RECRUITING
Breast Cancer|Breast Cancer Stage I|Breast Cancer Stage II|Breast Cancer Stage III
DRUG: T-DM1|DRUG: Capecitabine|RADIATION: External Beam Radiation Therapy 0|RADIATION: External Beam Radiation Therapy 1
University of Virginia
null
INTERVENTIONAL
NCT02521077
Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer
https://clinicaltrials.gov/study/NCT02521077
WITHDRAWN
Fatigue
DRUG: Ascorbic Acid|OTHER: Normal Saline
Midwestern Regional Medical Center
null
INTERVENTIONAL
NCT03789877
A Home-Based Walking Program and rTMS in Helping Breast Cancer Survivors Get More Physical Activity
https://clinicaltrials.gov/study/NCT03789877
COMPLETED
Cancer Survivor|Invasive Breast Carcinoma
OTHER: Physical Activity|OTHER: Questionnaire Administration|PROCEDURE: Repetitive Transcranial Magnetic Stimulation|PROCEDURE: Sham Intervention
Roswell Park Cancer Institute
null
INTERVENTIONAL
NCT01980277
Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast Cancer
https://clinicaltrials.gov/study/NCT01980277
TERMINATED
Breast Cancer
DRUG: LY2780301 + paclitaxel
Institut Paoli-Calmettes
null
INTERVENTIONAL
NCT05587777
Monitoring of Chronic Conditions in Breast Cancer
https://clinicaltrials.gov/study/NCT05587777
RECRUITING
Breast Cancer|Chronic Fatigue Syndrome
null
Helse Stavanger HF
null
OBSERVATIONAL
NCT04767594
First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.
https://clinicaltrials.gov/study/NCT04767594
RECRUITING
Breast Neoplasms
DRUG: Palbociclib + endocrine therapy
Pfizer
null
OBSERVATIONAL
NCT00148694
Preoperative Cisplatin in Early Stage Breast Cancer
https://clinicaltrials.gov/study/NCT00148694
COMPLETED
Breast Cancer
DRUG: Cisplatin
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center|Massachusetts General Hospital|Brigham and Women's Hospital|Breast Cancer Research Foundation
INTERVENTIONAL
NCT03043794
Study of Stereotactic Radiotherapy for Breast Cancer
https://clinicaltrials.gov/study/NCT03043794
RECRUITING
Breast Cancer
RADIATION: Stereotactic Body Radiation SBRT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
null
INTERVENTIONAL
NCT03321929
Intraoperative Detection of Residual Cancer in Breast Cancer
https://clinicaltrials.gov/study/NCT03321929
COMPLETED
Breast Cancer
COMBINATION_PRODUCT: LUM Imaging System
Lumicell, Inc.
National Cancer Institute (NCI)
INTERVENTIONAL
NCT04953377
PFMT Educational Intervention for Patients With Advancer Breast Cancer
https://clinicaltrials.gov/study/NCT04953377
RECRUITING
Advanced Breast Cancer
BEHAVIORAL: PFMT educational intervention
Onkologikoa
null
INTERVENTIONAL
NCT01594177
Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy
https://clinicaltrials.gov/study/NCT01594177
COMPLETED
Unilateral HER2 Positive Breast Cancer
DRUG: Afatinib|DRUG: Trastuzumab|DRUG: Paclitaxel|DRUG: Epirubicin|DRUG: Cyclophosphamide
German Breast Group
Boehringer Ingelheim
INTERVENTIONAL
NCT01625429
Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast Cancer
https://clinicaltrials.gov/study/NCT01625429
UNKNOWN
Breast Cancer
DRUG: nab-paclitaxel
Shanghai Cancer Hospital, China
null
INTERVENTIONAL
NCT05928429
Effects of Cryotherapy on Taxane-Induced Neuropathy in Patients With Breast Cancer
https://clinicaltrials.gov/study/NCT05928429
RECRUITING
CIPN - Chemotherapy-Induced Peripheral Neuropathy|Breast Cancer
DEVICE: Elasto-Gel™ mitts for hands: TM7008, and slippers for feet: SL3000; Southwest Technologies, Inc., North Kansas City, MO, USA
Maria Lendorf
Danish Cancer Society|Aarhus University Hospital|Nordsjællands Hospital, Denmark|Hospital of Southern Jutland
INTERVENTIONAL
NCT00333229
A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss
https://clinicaltrials.gov/study/NCT00333229
TERMINATED
Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women
DRUG: Zoledronic Acid|DRUG: Placebo
Novartis Pharmaceuticals
null
INTERVENTIONAL
NCT04755829
Breath Test to Predict Breast Cancer and Outcome of Mammography
https://clinicaltrials.gov/study/NCT04755829
UNKNOWN
Breast Cancer|Abnormal Mammogram, Unspecified
DEVICE: BreathX test for breath VOCs
Menssana Research, Inc.
Mount Vernon Cancer Centre|Zuyderland Medical Centre|University of Erlangen-Nürnberg
OBSERVATIONAL
NCT01978977
Maintenance Bevacizumab or Observation After Taxane Based First Line Chemotherapy In Metastatic Breast Cancer
https://clinicaltrials.gov/study/NCT01978977
COMPLETED
Metastatic Breast Cancer
null
Hellenic Oncology Research Group
null
OBSERVATIONAL
NCT05275777
A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer
https://clinicaltrials.gov/study/NCT05275777
RECRUITING
HER2-negative Breast Cancer|Advanced Solid Tumor
DRUG: ADG106|DRUG: Doxorubicin|DRUG: Cyclophosphamide|DRUG: Paclitaxel
National University Hospital, Singapore
Adagene Inc
INTERVENTIONAL
NCT05257577
Factors Influencing Breast Cancer Resection Volumes And Their Impact on Treatment Outcome (FIBRATIO)
https://clinicaltrials.gov/study/NCT05257577
ENROLLING_BY_INVITATION
Breast Cancer|Quality of Life|Patient Satisfaction|Resection Margin|Surgical Margin|Multidisciplinary Communication
PROCEDURE: Breast conserving surgery
Tampere University Hospital
Jyväskylä Central Hospital|Turku University Hospital|Kuopio University Hospital|North Karelia Central Hospital
OBSERVATIONAL
NCT00849329
A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer
https://clinicaltrials.gov/study/NCT00849329
COMPLETED
Neoplasms, Breast
DRUG: lapatinib|DRUG: lapatinib plus esomeprazole
GlaxoSmithKline
null
INTERVENTIONAL
NCT04881929
Study of KN026 in Combination With Docetaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
https://clinicaltrials.gov/study/NCT04881929
RECRUITING
Breast Cancer
DRUG: KN026
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
null
INTERVENTIONAL
NCT04341129
Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)
https://clinicaltrials.gov/study/NCT04341129
COMPLETED
Breast Neoplasms|Breast Diseases|Breast Fibroadenoma|Breast Cancer
DRUG: Abbreviated MRI protocol: initial experience with Dotarem® (Gadoterate Meglumine)
University of Chicago
Guerbet
INTERVENTIONAL
NCT00662129
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
https://clinicaltrials.gov/study/NCT00662129
COMPLETED
Breast Cancer
BIOLOGICAL: bevacizumab|DRUG: gemcitabine hydrochloride|DRUG: paclitaxel albumin-stabilized nanoparticle formulation
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
INTERVENTIONAL
NCT04012229
IMpact of Breast cAncer Gene Status on Survival in Adjuvant Breast Cancer (IMBASSA)
https://clinicaltrials.gov/study/NCT04012229
COMPLETED
Breast Cancer|BRCA1 Mutation|BRCA2 Mutation
GENETIC: BRCA mutation
Centre Hospitalier Universitaire de Besancon
null
OBSERVATIONAL
NCT02041429
Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca
https://clinicaltrials.gov/study/NCT02041429
COMPLETED
Recurrent Breast Cancer|Metastatic Breast Cancer
DRUG: Ruxolitinib|DRUG: Paclitaxel
Dana-Farber Cancer Institute
Incyte Corporation
INTERVENTIONAL
NCT00385177
Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors
https://clinicaltrials.gov/study/NCT00385177
COMPLETED
Breast Neoplasms|Colorectal Neoplasms|Pancreatic Neoplasms|Pelvic Neoplasms|Lung Neoplasms
DRUG: SN2310 Injectable Emulsion
Achieve Life Sciences
null
INTERVENTIONAL
NCT05564377
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
https://clinicaltrials.gov/study/NCT05564377
RECRUITING
Advanced Malignant Solid Neoplasm|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Locally Advanced Malignant Solid Neoplasm|Malignant Female Reproductive System Neoplasm|Metastatic HER2-Negative Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Recurrent Endometrial Carcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Malignant Female Reproductive System Neoplasm|Recurrent Malignant Solid Neoplasm|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Unresectable HER2-Negative Breast Carcinoma|Unresectable Malignant Solid Neoplasm
DRUG: Alpelisib|DRUG: Binimetinib|PROCEDURE: Biopsy|PROCEDURE: Biospecimen Collection|PROCEDURE: Bone Marrow Aspiration|PROCEDURE: Bone Scan|PROCEDURE: Computed Tomography|PROCEDURE: Echocardiography|DRUG: Fluorouracil|DRUG: Fulvestrant|DRUG: Ipatasertib|DRUG: Leucovorin|PROCEDURE: Magnetic Resonance Imaging|PROCEDURE: Multigated Acquisition Scan|PROCEDURE: Mutation Carrier Screening|DRUG: Neratinib Maleate|DRUG: Nilotinib Hydrochloride Monohydrate|DRUG: Olaparib|DRUG: Oxaliplatin|DRUG: Paclitaxel|DRUG: Palbociclib|BIOLOGICAL: Panitumumab|PROCEDURE: Positron Emission Tomography|DRUG: Selumetinib Sulfate|DRUG: Sotorasib
National Cancer Institute (NCI)
null
INTERVENTIONAL
NCT04689529
Unnecessary Mastectomy Due to False Size Prediction by Preoperative Imaging Studies in Breast Cancer
https://clinicaltrials.gov/study/NCT04689529
ACTIVE_NOT_RECRUITING
Breast Cancer|Surgery|IMAGE|Chemotherapy Effect
DIAGNOSTIC_TEST: Preoperative imaging study
Seoul National University Hospital
null
INTERVENTIONAL
NCT00003877
Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer
https://clinicaltrials.gov/study/NCT00003877
COMPLETED
Breast Cancer
BIOLOGICAL: filgrastim|DRUG: carboplatin|DRUG: cyclophosphamide|DRUG: paclitaxel|DRUG: thiotepa|PROCEDURE: in vitro-treated bone marrow transplantation|PROCEDURE: in vitro-treated peripheral blood stem cell transplantation
Roswell Park Cancer Institute
National Cancer Institute (NCI)
INTERVENTIONAL
NCT01649271
Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer.
https://clinicaltrials.gov/study/NCT01649271
COMPLETED
Breast Neoplasms|Stomach Neoplasms
DRUG: Herceptin|DRUG: afatinib|DRUG: trastuzumab|DRUG: Herceptin|DRUG: afatinib|DRUG: afatinib
Boehringer Ingelheim
null
INTERVENTIONAL
NCT01702571
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
https://clinicaltrials.gov/study/NCT01702571
COMPLETED
Breast Cancer
DRUG: Trastuzumab Emtansine
Hoffmann-La Roche
null
INTERVENTIONAL
NCT01120171
Myocet Plus Endoxan for Older Patients With Breast Cancer
https://clinicaltrials.gov/study/NCT01120171
TERMINATED
Breast Cancer
DRUG: Cyclophosphamide|DRUG: Liposomal-encapsulated doxorubicin
Hellenic Oncology Research Group
null
INTERVENTIONAL
NCT03939871
A Study of Fluvestrant Combined With Oral Vinorelbine in Hormone Receptor-positive Advanced Breast Cancer
https://clinicaltrials.gov/study/NCT03939871
UNKNOWN
Hormone Receptor Positive Advanced Breast Cancer
DRUG: fluvestrant + oral vinorelbine
Chinese Academy of Medical Sciences
null
INTERVENTIONAL
NCT05894239
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
https://clinicaltrials.gov/study/NCT05894239
RECRUITING
Metastatic Breast Cancer
DRUG: Inavolisib|DRUG: Phesgo|DRUG: Placebo|DRUG: Taxane-based Chemotherapy|DRUG: Optional Endocrine Therapy of Investigator's Choice
Hoffmann-La Roche
null
INTERVENTIONAL
NCT00393939
Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer
https://clinicaltrials.gov/study/NCT00393939
COMPLETED
Breast Neoplasms
DRUG: Sunitinib malate|DRUG: Taxotere
Pfizer
null
INTERVENTIONAL
NCT00967239
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2
https://clinicaltrials.gov/study/NCT00967239
UNKNOWN
Breast Cancer
GENETIC: DNA analysis|GENETIC: polymorphism analysis|OTHER: laboratory biomarker analysis|OTHER: pharmacogenomic studies
NSABP Foundation Inc
National Cancer Institute (NCI)
OBSERVATIONAL
NCT01367639
Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers
https://clinicaltrials.gov/study/NCT01367639
COMPLETED
Hereditary Breast and Ovarian Cancer Syndrome
BEHAVIORAL: Inquiry Based Stress Reduction (IBSR) program
Sheba Medical Center
null
INTERVENTIONAL
NCT03265379
Improving Quality of Life for Patients With Breast Cancer Invading the Chest Wall: A Prospective Registry For Patients Undergoing Full Thickness Chest Wall Resection
https://clinicaltrials.gov/study/NCT03265379
RECRUITING
Breast Cancer
OTHER: FACT-B and Brief Pain Inventory
University Health Network, Toronto
null
OBSERVATIONAL
NCT04028479
The Registry of Oncology Outcomes Associated With Testing and Treatment
https://clinicaltrials.gov/study/NCT04028479
RECRUITING
Adenocarcinoma|Adenocystic Carcinoma|Anal Cancer|Appendix Cancer|Brain Tumor|Glioblastoma|Astrocytoma|Bile Duct Cancer|Cholangiocarcinoma|Bladder Cancer|Bone Cancer|Synovial Sarcoma|Chondrosarcoma|Liposarcoma|Sarcoma, Kaposi|Sarcoma,Soft Tissue|Sarcoma|Osteosarcoma|CNS Cancer|Brain Stem Neoplasms|Breast Cancer|Cervical Cancer|Colorectal Cancer|Rectal Cancer|Colon Cancer|Esophageal Cancer|Esophagus Cancer|Cancer of Colon|Pancreatic Cancer|Cancer of Pancreas|Testis Cancer|Testicular Cancer|Ureter Cancer|Renal Cell Carcinoma|Kidney Cancer|Gestational Trophoblastic Tumor|Head and Neck Neoplasms|Parotid Tumor|Larynx Cancer|Tongue Cancer|Pharynx Cancer|Salivary Gland Cancer|Acute Myeloid Leukemia|Chronic Myeloid Leukemia|Acute Lymphoblastic Leukemia|Multiple Myeloma|Non Hodgkin Lymphoma|Carcinoid Tumor|Lung Cancer|Neuroendocrine Tumors|Mesothelioma|Thyroid Cancer|Parathyroid Neoplasms|Adrenal Cancer|Small Bowel Cancer|Stomach Cancer|Liver Cancer|Hepatic Cancer|Melanoma|Skin Cancer|Unknown Primary Tumors|Uterine Cancer|Fallopian Tube Cancer|Ovarian Cancer|Prostate Cancer|Vaginal Cancer|Penile Cancer|Vulvar Cancer|Waldenstrom Macroglobulinemia|Cancer, Advanced|Thymus Cancer|Nasopharyngeal Carcinoma|Multiple Endocrine Neoplasia|Pheochromocytoma|Small Cell Carcinoma|Pulmonary Carcinoma
DIAGNOSTIC_TEST: Biomarker Testing (L)|DRUG: Systemic Treatment (T)|OTHER: Patient Reported Outcomes (P)
Taproot Health
null
OBSERVATIONAL
NCT00419679
Use of Hair to Diagnose Breast Cancer
https://clinicaltrials.gov/study/NCT00419679
UNKNOWN
Breast Neoplasms
PROCEDURE: x-ray diffraction of human hair
Fermiscan Ltd
null
INTERVENTIONAL
NCT03176979
Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast Cancer
https://clinicaltrials.gov/study/NCT03176979
COMPLETED
Breast Carcinoma
OTHER: Contrast Agent|PROCEDURE: Digital Tomosynthesis Mammography|PROCEDURE: Dual-Energy Contrast-Enhanced Digital Spectral Mammography
University of Southern California
National Cancer Institute (NCI)
INTERVENTIONAL
NCT05739591
Long-term Safety and Efficacy of GBG Study Participants
https://clinicaltrials.gov/study/NCT05739591
RECRUITING
Breast Cancer
null
German Breast Group
null
OBSERVATIONAL
NCT02902991
The Study on the Clinical Utility of Liquid Biopsy in Breast Cancer
https://clinicaltrials.gov/study/NCT02902991
UNKNOWN
Breast Cancer
null
Peking Union Medical College
null
OBSERVATIONAL
NCT01254591
Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer
https://clinicaltrials.gov/study/NCT01254591
UNKNOWN
Breast Cancer|Colorectal Cancer|Esophageal Cancer|Head and Neck Cancer|Lung Cancer
OTHER: 18F-fluoromisonidazole|OTHER: fluorescence angiography|OTHER: laboratory biomarker analysis|PROCEDURE: infrared thermography|PROCEDURE: magnetic resonance imaging|PROCEDURE: therapeutic conventional surgery|RADIATION: [18F]-ML-10|RADIATION: fludeoxyglucose F 18|RADIATION: rubidium Rb-82
University College London (UCL) Cancer Institute
null
INTERVENTIONAL
NCT00046891
EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
https://clinicaltrials.gov/study/NCT00046891
COMPLETED
Breast Cancer|Neurotoxicity
DRUG: Ginkgo Biloba|OTHER: Placebo
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
INTERVENTIONAL
NCT05986071
I/II Phase Study Evaluating M1774 in Combination With Fulvestrant in HR+ and HER2- Advanced Breast Cancers
https://clinicaltrials.gov/study/NCT05986071
NOT_YET_RECRUITING
Breast Cancer
DRUG: M1774|DRUG: Fulvestrant injection
Institut Paoli-Calmettes
Merck Sharp & Dohme LLC|National Cancer Institute, France
INTERVENTIONAL
NCT02248571
Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab
https://clinicaltrials.gov/study/NCT02248571
COMPLETED
Breast Cancer Recurrent|HER2/Neu-negative Carcinoma of Breast|Hormone Receptor Positive Malignant Neoplasm of Breast
DRUG: Bevacizumab|DRUG: Capecitabine|DRUG: Everolimus|DRUG: Exemestane|OTHER: Patient questionaires
iOMEDICO AG
Arbeitsgemeinschaft fur Internistische Onkologie|Novartis Pharmaceuticals
INTERVENTIONAL
NCT04496739
Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)
https://clinicaltrials.gov/study/NCT04496739
RECRUITING
Atypical Hyperplasia of the Breast|Lobular Breast Carcinoma In Situ|Pleomorphic Lobular Breast Carcinoma In Situ
BEHAVIORAL: Cancer Educational Materials|OTHER: Decision Aid|OTHER: Decision Aid|OTHER: Interview|OTHER: Questionnaire Administration
SWOG Cancer Research Network
National Cancer Institute (NCI)
INTERVENTIONAL
NCT03257839
Delphinus SoftVue Prospective Case Collection - ARM 1
https://clinicaltrials.gov/study/NCT03257839
COMPLETED
Breast Neoplasms
DEVICE: Routine Full-Field Digital Mammography|DEVICE: Routine Digital Breast Tomosynthesis|DEVICE: Automated Whole Breast Ultrasound
Delphinus Medical Technologies, Inc.
null
OBSERVATIONAL
NCT05720039
Robotic vs. Open NSM for Early Stage Breast Cancer
https://clinicaltrials.gov/study/NCT05720039
RECRUITING
Breast Cancer Female|Breast Cancer|Breast Cancer, Early-Onset|Breast Disease|Breast
DEVICE: Robotic NSM|PROCEDURE: Open NSM
Intuitive Surgical
null
INTERVENTIONAL
NCT00074139
Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer
https://clinicaltrials.gov/study/NCT00074139
WITHDRAWN
Breast Cancer
DRUG: cyclophosphamide|DRUG: docetaxel|DRUG: doxorubicin hydrochloride
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
INTERVENTIONAL
NCT04657679
Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts
https://clinicaltrials.gov/study/NCT04657679
TERMINATED
Breast Cancer
DRUG: Ribociclib
Georgetown University
Medstar Health Research Institute|Breast Cancer Research Foundation|Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS)
INTERVENTIONAL
NCT00496379
ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases
https://clinicaltrials.gov/study/NCT00496379
TERMINATED
Breast Cancer|CNS Disease
DRUG: ZK219477
Nancy Lin, MD
Brigham and Women's Hospital|Bayer|Breast Cancer Research Foundation
INTERVENTIONAL
NCT05633979
Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast Cancer
https://clinicaltrials.gov/study/NCT05633979
RECRUITING
Breast Cancer
DRUG: Trastuzumab deruxtecan|DRUG: Valemetostat
M.D. Anderson Cancer Center
Daiichi Sankyo
INTERVENTIONAL
NCT01463891
Post-marketing Surveillance for the Clinical Safety and Effectiveness of Eribulin Mesylate in Patients With Inoperable or Recurrent Breast Cancer (Study HAL01S)
https://clinicaltrials.gov/study/NCT01463891
COMPLETED
Inoperable or Recurrent Breast Cancer
DRUG: Eribulin Mesylate
Eisai Co., Ltd.
null
OBSERVATIONAL
NCT00161291
Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer
https://clinicaltrials.gov/study/NCT00161291
COMPLETED
Breast Cancer
DRUG: Letrozole in combination with Bevacizumab
University of Alabama at Birmingham
Genentech, Inc.
INTERVENTIONAL
NCT05365191
A Study Evaluating Near-infrared Zone II Imaging in Sentinel Lymph Node Mapping in Breast Cancer Patients
https://clinicaltrials.gov/study/NCT05365191
RECRUITING
Breast Cancer|Sentinel Lymph Node
PROCEDURE: Near infrared fluorescence navigated sentinel lymph node mapping
National Taiwan University Hospital Hsin-Chu Branch
National Yang Ming Chiao Tung University
INTERVENTIONAL
NCT01846091
Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer
https://clinicaltrials.gov/study/NCT01846091
COMPLETED
Estrogen Receptor Negative|Estrogen Receptor Positive|Head and Neck Squamous Cell Carcinoma|HER2/Neu Negative|HER2/Neu Positive|Invasive Breast Carcinoma|Progesterone Receptor Negative|Progesterone Receptor Positive|Recurrent Head and Neck Carcinoma|Stage IV Breast Cancer|Triple-Negative Breast Carcinoma
OTHER: Laboratory Biomarker Analysis|BIOLOGICAL: Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Mayo Clinic
National Cancer Institute (NCI)
INTERVENTIONAL
NCT03564171
Prehabilitation for Women Undergoing Pre-operative Chemotherapy for Breast Cancer
https://clinicaltrials.gov/study/NCT03564171
COMPLETED
Breast Cancer|Rehabilitation|Neoadjuvant Therapy|Feasibility Studies
COMBINATION_PRODUCT: Prehabilitation
Sunnybrook Health Sciences Centre
University Health Network, Toronto
INTERVENTIONAL
NCT02780271
Diet and Physical Activity Changes Among Latina Breast Cancer Survivors
https://clinicaltrials.gov/study/NCT02780271
COMPLETED
Breast Cancer
BEHAVIORAL: In-person education|BEHAVIORAL: E-communication|BEHAVIORAL: Control
Columbia University
National Cancer Institute (NCI)
INTERVENTIONAL
NCT02620371
Efficacy of Ketamine Added to Local Anesthetic in Modified Pectoral Block for Management of Postoperative Pain
https://clinicaltrials.gov/study/NCT02620371
COMPLETED
Breast Cancer
PROCEDURE: modified pectoral block
Assiut University
null
INTERVENTIONAL
NCT00246571
Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer
https://clinicaltrials.gov/study/NCT00246571
COMPLETED
Breast Neoplasms
DRUG: SU011248|DRUG: Chemotherapy
Pfizer
null
INTERVENTIONAL
NCT05891171
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
https://clinicaltrials.gov/study/NCT05891171
RECRUITING
Advanced Cancer|Advanced Malignancies|Bladder Cancer|Cervical Cancer|Esophageal Cancer|Gastric Cancer|Gastroesophageal-junction Cancer (GEJ)|Head and Neck Squamous Cell Carcinoma (HNSCC)|Non-Small Cell Lung Cancer (NSCLC)|Ovarian Cancer|Renal Cell Carcinoma (RCC)|Triple Negative Breast Cancer (TNBC)
DRUG: AB598|DRUG: Zimberelimab|DRUG: Carboplatin|DRUG: Pemetrexed|DRUG: Fluorouracil|DRUG: Leucovorin|DRUG: Oxaliplatin
Arcus Biosciences, Inc.
null
INTERVENTIONAL
NCT04175639
mHealth Behavioral Cancer Pain Intervention for Medically Undeserved Patients
https://clinicaltrials.gov/study/NCT04175639
RECRUITING
Breast Cancer
BEHAVIORAL: Mobile Health Pain Coping Skills Training (mPCST)
Duke University
null
INTERVENTIONAL
NCT01313039
Evaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast Cancer
https://clinicaltrials.gov/study/NCT01313039
COMPLETED
Breast Cancer
DRUG: AZ6244
University of Miami
null
INTERVENTIONAL
NCT00976339
Study of Vitamin D for Premenopausal Women at High Risk for Breast Cancer
https://clinicaltrials.gov/study/NCT00976339
COMPLETED
Breast Cancer
DRUG: Cholecalciferol
Katherine D. Crew
Prevent Cancer Foundation
INTERVENTIONAL
NCT05287139
QOL of Women With HR-Positive Metastatic BC Treated in the First-line Setting: Comparison Between Public and Private Institutions.
https://clinicaltrials.gov/study/NCT05287139
ENROLLING_BY_INVITATION
Quality of Life|Breast Neoplasm Female
OTHER: Quality of Life
Beneficência Portuguesa de São Paulo
null
OBSERVATIONAL
NCT03579979
Sentinel Lymph Node Biopsy in Breast Cancer Surgery Using ICG
https://clinicaltrials.gov/study/NCT03579979
COMPLETED
Sentinel Lymph Node|Breast Cancer
DRUG: Methylene Blue|DRUG: Indocyanine Green
Chinese Academy of Sciences
Beijing Digital Precesion Medicine Company|Cancer Institute and Hospital, Chinese Academy of Medical Sciences|Beijing Friendship Hospital|Tangshan People's Hospital|The Second Hospital of Hebei Medical University
INTERVENTIONAL
NCT00952679
Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients
https://clinicaltrials.gov/study/NCT00952679
UNKNOWN
Breast Cancer
DEVICE: Breast Lesion Localization Needles (interv)
Fudan University
null
INTERVENTIONAL
NCT02022579
DCE-MRI and DWI for Detection and Diagnosis of Breast Cancer
https://clinicaltrials.gov/study/NCT02022579
UNKNOWN
Breast Cancer|BIRADS 3|BIRADS 4|BIRADS 5
PROCEDURE: DCE-MRI and DWI
American College of Radiology Imaging Network
National Cancer Institute (NCI)|Eastern Cooperative Oncology Group
INTERVENTIONAL
NCT04166279
The Recovery of Reaching Movement in Breast Cancer Survivors: Two Different Rehabilitative Protocols in Comparison
https://clinicaltrials.gov/study/NCT04166279
COMPLETED
Breast Cancer|Breast Cancer Lymphedema|Pain|Pain, Postoperative|Pain, Chronic|Mastectomy; Lymphedema|Breast Surgery
OTHER: Single rehabilitative treatment|OTHER: Group rehabilitative treatment
University of Roma La Sapienza
null
INTERVENTIONAL
NCT01479179
Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab
https://clinicaltrials.gov/study/NCT01479179
WITHDRAWN
Breast Cancer
DRUG: AMG 479|DRUG: Trastuzumab
M.D. Anderson Cancer Center
Amgen
INTERVENTIONAL
NCT05011279
Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives)
https://clinicaltrials.gov/study/NCT05011279
COMPLETED
Breast Cancer Survivor|Breast Cancer|Fitness Trackers
OTHER: Move Together app/Garmin Activity Tracker
Dana-Farber Cancer Institute
University of Massachusetts, Boston|University of Rochester|National Cancer Institute (NCI)
INTERVENTIONAL
NCT04683679
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
https://clinicaltrials.gov/study/NCT04683679
RECRUITING
Triple Negative Breast Cancer|TNBC - Triple-Negative Breast Cancer|Breast Cancer|Metastatic Breast Cancer
DRUG: Pembrolizumab|DRUG: Olaparib|RADIATION: Radiation
Memorial Sloan Kettering Cancer Center
null
INTERVENTIONAL
NCT04206891
CDH1 Germline Mutations in Lobular Breast Cancer
https://clinicaltrials.gov/study/NCT04206891
ACTIVE_NOT_RECRUITING
Lobular Breast Carcinoma|CDH1 Gene Inactivation
null
European Institute of Oncology
null
OBSERVATIONAL
NCT04583891
Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design
https://clinicaltrials.gov/study/NCT04583891
ACTIVE_NOT_RECRUITING
Depression, Anxiety|Engagement, Patient
BEHAVIORAL: IntelliCare|BEHAVIORAL: Psychoeducation|BEHAVIORAL: Coaching
University of Virginia
Northwestern University
INTERVENTIONAL
NCT05731791
Trial to Compare MRI-guided Precision Prone Irradiation (PPI) Versus CT-guided Breast Irradiation
https://clinicaltrials.gov/study/NCT05731791
RECRUITING
Breast Cancer
RADIATION: Radiation Therapy to partial breast
Weill Medical College of Cornell University
null
INTERVENTIONAL
NCT00014391
Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation
https://clinicaltrials.gov/study/NCT00014391
COMPLETED
Cancer
BIOLOGICAL: palivizumab|DRUG: ribavirin
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
INTERVENTIONAL
NCT05297591
Identifying Prognostic Variables for Persistent Upper Limb Dysfunctions After Breast Cancer Treatment
https://clinicaltrials.gov/study/NCT05297591
RECRUITING
Breast Cancer
OTHER: assessment of UL function and prognostic factors
KU Leuven
Universitaire Ziekenhuizen KU Leuven|Vrije Universiteit Brussel
INTERVENTIONAL